BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2877171)

  • 1. Ifosfamide/mesna nomogram and serum albumin.
    Hill PG; Harrop JS
    Lancet; 1986 Oct; 2(8513):986. PubMed ID: 2877171
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide/mesna nomogram and serum albumin.
    Constantine G; Meanwell C; Blackledge G
    Lancet; 1986 Nov; 2(8515):1102. PubMed ID: 2877256
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalopathy with rapid infusion ifosfamide/mesna.
    Perren TJ; Turner RC; Smith IE
    Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ; Watkin SW
    Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
    Klein HO; Wickramanayake PD; Christian E; Coerper C; Graf L
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():83-92. PubMed ID: 6414699
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding ifosfamide/mesna encephalopathy.
    Meanwell CA; Kelly KA; Blackledge G
    Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
    [No Abstract]   [Full Text] [Related]  

  • 7. Infusion of ifosfamide plus mesna.
    Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
    Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
    Focan C; Boossy J; Focan-Henrard D; Reginster M; Claessens JJ
    Cancer Chemother Pharmacol; 1989; 23(3):192-3. PubMed ID: 2493996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
    Klein HO; Wickramanayake PD; Coerper C; Christian E; Pohl J; Brock N
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():167-73. PubMed ID: 6414691
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
    Klein HO; Dias Wickramanayake P; Coerper C; Christian E
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S19. PubMed ID: 3102091
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W; Stempinski E; Göbel D; Thalmann U
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion of ifosphamide plus mesna.
    Shaw IC; Rose JW
    Lancet; 1984 Jun; 1(8390):1353-4. PubMed ID: 6145051
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesna: continuous or bolus infusion?
    Willemse PH; de Vries EG
    J Clin Oncol; 1989 Jun; 7(6):817-9. PubMed ID: 2497231
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
    Stuart-Harris R; Harper PG; Kaye SB; Wiltshaw E
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():163-4. PubMed ID: 6414689
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cantwell BM; Harris AL; Bozzino JM
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S29. PubMed ID: 3028660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide/mesna encephalopathy.
    McCallum AK
    Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
    [No Abstract]   [Full Text] [Related]  

  • 18. Ifosfamide, mesna and vincristine in paediatric oncology.
    de Kraker J; Voûte PA
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():165-6. PubMed ID: 6414690
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH; de Jong PE; Elema JD; Mulder NH
    Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.